Shin Nippon Biomedical Laboratories, Ltd. (2395.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 58.87B |
| Enterprise Value | 81.59B |
| P/E Ratio | 10.99 |
| PEG Ratio | 1.81 |
| Price/Sales Ratio | 1.74 |
| Price/Book Ratio | 1.41 |
| Enterprise/Revenue | 2.43 |
| Enterprise/EBITDA | 10.58 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.16 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | 0.05 |
| Return On Equity | 0.12 |
Income Statement
| Revenue | 32.52B |
| Revenue/Share | 814.67 |
| Gross Profit | 15.83B |
| EBITDA | 6.09B |
| Net Income | 4.57B |
| Diluted EPS | 109.69 |
Balance Sheet
| Total Cash | 14.33B |
| Total Cash/Share | 344.31 |
| Total Debt | 37.58B |
| Total Debt/Equity | 0.9 |
| Current Ratio | 1.02 |
| Book Value Per Share | 1,015.23 |
Price History
| 52-Week Change | -16.64 |
| 52-Week High | 2,005 |
| 52-Week Low | 1,067 |
| Moving Average 50 Days | 1,264.12 |
| Moving Average 200 Days | 1,478.22 |
Statistics
| Average Volume | 230,184 |
| Shares Outstanding | 41.63M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 50 |
| Trailing Annual Dividend Yield | 3.53 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | September 27, 2005 |
AD
